Search
Search Funnelback University
1 -
6 of
6
search results for `Financial Economics` |u:techpolicymphil.blog.jbs.cam.ac.uk
Fully-matching results
-
https://techpolicymphil.blog.jbs.cam.ac.uk/tag/rcts/feed/
https://techpolicymphil.blog.jbs.cam.ac.uk/tag/rcts/feed/22 May 2023: Meningitis B from Novartis, where the US FDA still had not granted permission even long after it was in regular use in other major economics including the EU, Australia, Canada, etc. ... In response to questions about liability and the economics of -
https://techpolicymphil.blog.jbs.cam.ac.uk/tag/ebola/feed/
https://techpolicymphil.blog.jbs.cam.ac.uk/tag/ebola/feed/22 May 2023: Meningitis B from Novartis, where the US FDA still had not granted permission even long after it was in regular use in other major economics including the EU, Australia, Canada, etc. ... In response to questions about liability and the economics of -
https://techpolicymphil.blog.jbs.cam.ac.uk/tag/ethics/feed/
https://techpolicymphil.blog.jbs.cam.ac.uk/tag/ethics/feed/22 May 2023: Meningitis B from Novartis, where the US FDA still had not granted permission even long after it was in regular use in other major economics including the EU, Australia, Canada, etc. ... In response to questions about liability and the economics of -
https://techpolicymphil.blog.jbs.cam.ac.uk/tag/pharma/feed/
https://techpolicymphil.blog.jbs.cam.ac.uk/tag/pharma/feed/22 May 2023: Meningitis B from Novartis, where the US FDA still had not granted permission even long after it was in regular use in other major economics including the EU, Australia, Canada, etc. ... In response to questions about liability and the economics of -
https://techpolicymphil.blog.jbs.cam.ac.uk/tag/vaccines/feed/
https://techpolicymphil.blog.jbs.cam.ac.uk/tag/vaccines/feed/22 May 2023: Meningitis B from Novartis, where the US FDA still had not granted permission even long after it was in regular use in other major economics including the EU, Australia, Canada, etc. ... In response to questions about liability and the economics of -
GSK and the Ebola vaccine: drug approval, ethics, corporate…
https://techpolicymphil.blog.jbs.cam.ac.uk/2014/11/30/gsk-and-the-ebola-vaccine-drug-approval-ethics-corporate-citizenship-and-regulatory-strategy/major economics including the EU, Australia, Canada, etc. ... In response to questions about liability and the economics of vaccines, Witty claimed “we have taken financial risks, have taken decisions without being asked and we’ve made decisions
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.